What to invest in 2020 on Wall Street? High-potential titles

The sectors that could drive American stock exchanges

Forecasts for 2020 on Wall Street show specific sectors in the foreground. After another year the semiconductors skyrocketed, experts thought it was time to sell. Many factors pushed on the sell button. First of all the well-known diatribes on commercial issues. But even the cyclical nature of the sector seemed to have now suggested selling semiconductor stocks. But the latest developments have made many people change their minds and 2020 could turn out to be a better year than experts had expected.

What to invest in 2020 on Wall Street?

Looking at what to buy now on Wall Street, the semiconductor landscape is therefore in the foreground. For Stifel, some titles like Lam Research (LRCX), can count on a renewed bullish scenario. Maybe also thanks to the results of the third quarter just published. Accounts that predict that 2020 can be one of the best years. Another interesting action to buy on Wall Street is Applied Materials Inc. (AMAT), a world leader in precision engineering solutions for the semiconductor industry.

The sector preferred by Stifel analysts

Stifel analysts are very positive on the stock so as to consider it the first choice in a winning portfolio for 2020. The optimism comes not only for the input, already mentioned, on semiconductors. The advice of the experts to buy also comes from the diffusion on the market of larger screens, with a higher resolution and from the arrival on the market of flexible displays. Add to this a dividend of 1.57%.

What to buy on Wall Street according to UBS

What to invest in 2020 on Wall Street? For UBS a sector to buy is that of Biotech. In this regard, the preferred titles are Bioxcel Therapeutics (BTAI) to which the bank assigns a $ 13 buy-to-price rating. Although there will be no profits, so no dividend for the two-year period 2019-2020, the stock has a performance of 142% since the beginning of the year. No dividends even for Applied Therapeutics (APLT). However, the rating buy and target price of $ 20 in the last 3 months has set aside + 11% on shares.

The ace up its sleeve: the dividend

Who instead offers a return on the coupon front is Gilead (GILD). Also in this case from UBS they talk about buying (rating buy) with a target price of 77 dollars. For the dividend yield, the shareholder premium is 3.9% for this year and for the next one.

deepening

Warren Buffett's 2020 tips